Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 05/21 04:24:21 pm
7582 ILa   +0.03%
05/21ACTELION : Teva on FDA name and shame list
AQ
05/18TEVA PHARMACEUT : CORRECTING and REPLACING Teva Announces Publicatio..
PU
05/18FDA approves Aimovig as first CGRP inhibitor for migraines
AQ
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
05/14/2018 05/15/2018 05/16/2018 05/17/2018 05/21/2018 Date
7240(c) 7287(c) 7519(c) 7580(c) 7582 Last
932 109 949 767 1 971 893 845 658 880 588 Volume
+3.90% +0.65% +3.18% +0.81% +0.03% Change
More quotes
Financials (USD)
Sales 2018 19 600 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
Sales 2019 19 500 M
EBIT 2019 -
Net income 2019 -
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 1,10x
Capi. / Sales2019 1,10x
Capitalization 21 531 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products.It operates through two segments:... 
Sector
Pharmaceuticals
Calendar
06/05 | 03:30pmShareholder meeting
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
05/21ACTELION : Teva on FDA name and shame list
AQ
05/21TEVA PHARMACEUTICAL INDUSTRIES : Israel’s Teva on FDA blacklist of drugmak..
AQ
05/18TEVA PHARMACEUTICAL INDUSTRIES : CORRECTING and REPLACING Teva Announces Publica..
PU
05/18TEVA PHARMACEUTICAL INDUSTRIES LTD ( : Free Stock Performance Review on Teva Pha..
AC
05/18FDA approves Aimovig as first CGRP inhibitor for migraines
AQ
05/18Hikma reaffirms full-year revenue forecast, cites better generics business
RE
05/17BERKSHIRE HATHAWAY : Buffett's Berkshire Hathaway doubles its stake in Teva
AQ
05/16BERKSHIRE HATHAWAY : Buffett's Berkshire Hathaway doubles its stake in Teva
AQ
05/16Berkshire Increases Stake in Teva, Monsanto
AQ
05/15Florida and Texas Are Among Latest States to Sue Opioid Painkiller Companies
DJ
More news
Sector news : Pharmaceuticals - NEC
05/21MERCK AND : Ebola Vaccination Begins in Democratic Republic of Congo -- Update
DJ
05/21MERCK AND : Factbox - From sterling crises to Brexit, the tests of Bank of Engla..
RE
05/21ASTRAZENECA : potassium drug finally approved, threatening Vifor
RE
05/21EU Approves GlaxoSmithKline JV's Juluca HIV Treatment
DJ
05/21MERCK AND : Ebola Vaccine Arrives in Democratic Republic of Congo
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
05/20Cantor Fitzgerald Analysts Give Teva Pharmaceutical Industries $TEVA a $18.00.. 
05/19Teva Pharmaceutical Industries $TEVA Receives Consensus Rating of “Hold” from.. 
05/18Teva Pharmaceutical Industries : CORRECTING and REPLACING Teva Announces Publ.. 
05/18Teva Pharmaceutical Industries Ltd (ADR) : Free Stock Performance Review on T.. 
05/16Teva Pharmaceutical Industries Ltd, Once a Falling Machete, Is Spiking — Chas.. 
More tweets
Qtime:50
News from SeekingAlpha
05/21Amgen And Novartis Aimovig FDA Approval Gives First Mover Advantage, Will Tha.. 
05/21VALEANT PHARMACEUTICALS : Worth At Least $30 
05/18Amgen's first mover advantage with Aimovig bodes well - analysts 
05/18Investors bullish on biotechs after Trump drug pricing speech 
05/17Teva's Generic Restasis Could Punish Allergan 
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 18,5 $
Spread / Average Target -12%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED14.71%21 531
JOHNSON & JOHNSON-11.08%332 184
PFIZER-1.41%212 424
NOVARTIS-6.55%202 969
ROCHE HOLDING LTD.-8.90%193 622
MERCK AND COMPANY5.10%158 916